Panacea Life Sciences Holdings, Inc. Payments for Repurchase of Convertible Preferred Stock
Panacea Life Sciences Holdings, Inc. (PLSH) reported Payments for Repurchase of Convertible Preferred Stock of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock · last filed 2018-04-02
- Panacea Life Sciences Holdings, Inc. payments for repurchase of convertible preferred stock for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Panacea Life Sciences Holdings, Inc. payments for repurchase of convertible preferred stock for fiscal 2016 was $50.00K.
- Panacea Life Sciences Holdings, Inc. payments for repurchase of convertible preferred stock for fiscal 2015 was $0.00.
| Period end | Payments for Repurchase of Convertible Preferred Stock 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2016-12-31 | $50.00K 10-K · filed 2018-04-02 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 |